Lakefront Biotherapeutics (LKFT) Long-Term Investments (2023 - 2026)

Lakefront Biotherapeutics (LKFT) has 4 years of Long-Term Investments data on file, last reported at $56.1 million in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $56.1 million, up 4.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.1 million (up 4.9% YoY), and the FY2025 annual result was $54.5 million, down 74.53% from the prior year.
• Long-Term Investments rose to $56.1 million in Q1 2026 per LKFT's latest filing, from $54.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $213.9 million in Q4 2024 and troughed at $14.6 million in Q4 2023.
• A 4-year average of $69.3 million and a median of $54.2 million in 2025 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments jumped 1364.57% in 2024, then plunged 74.53% in 2025.
• A 4-year view of Long-Term Investments shows it stood at $14.6 million in 2023, then jumped by 1364.57% to $213.9 million in 2024, then sank by 74.53% to $54.5 million in 2025, then gained by 2.99% to $56.1 million in 2026.
• Business Quant data shows LKFT's Long-Term Investments at $56.1 million in Q1 2026, $54.5 million in Q4 2025, and $54.8 million in Q3 2025.